ArticleFrontiers in psychiatry2025
Investigating the attitude of psychiatrists towards the presence of stigma about COVID-19.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial: Community series in mental-health-related stigma and discrimination: prevention, role, and management strategies, volume III.Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The COVID-19 pandemic has led to significant global disruption, resulting in increased stigma and discrimination towards certain communities and populations affected by the virus. Given that psychiatrists play a crucial role in both preventing and treating the complications associated with disease-related stigma, this study aims to examine their attitude towards the stigma associated with COVID-19. Methods: This research utilized a cross-sectional survey design to evaluate psychiatrists' attitudes towards COVID-19 stigma. We used a 15-item researcher-made questionnaire with scores ranging from 15 to 75. The questionnaire was distributed to 131 psychiatrists in Tehran (capital city of Iran) from April 9, 2023 to May 26, 2023, with responses collected voluntarily. Data were analyzed with descriptive statistics, independent t-tests, and one-way ANOVA to evaluate stigma attitudes across demographic variables using SPSS software (version 25). Results: The Cronbach's alpha for the COVID-19 Stigma Attitude Scale for Psychiatrists (CSASP) was determined to be 0.861, indicating strong reliability. Moreover, all questions achieved acceptable corrected item-total correlation values above 0.2. It was revealed that the highest and lowest recorded scores were 68 and 25, respectively (average 51.16 ± 8.83). Also 19 individuals (14.5%) exhibited a weak attitude, 41 individuals (31.3%) displayed a rather weak attitude, 54 individuals (41.2%) showed a rather strong attitude, and 17 individuals (13%) demonstrated a strong attitude toward the presence of COVID-19 stigma. Furthermore, 96 individuals (73.3%) recognized stigma surrounding COVID-19 at the onset of the pandemic; of these, 11 (11.5%) disagreed with the idea of current stigma, while 18 (18.7%) had no opinion. Thus, 67 participants (69.8%) still believe such a stigma exists. Finally, 83 respondents (63.3%) acknowledged stigma related to AIDS and leprosy, with 53 (63.8%) of them also believing in the stigma surrounding COVID-19. Conclusion: The findings highlighted various attitudes towards the ongoing stigma associated with COVID-19, with most psychiatrists recognizing its persistence throughout the pandemic. The research also points to the interconnectedness of stigma across different diseases, emphasizing common societal factors like fear, misinformation, and cultural biases. This underscores the crucial role psychiatrists play in addressing stigma and its effects on society.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.